Oracefal
Category
Oracefal Brand names, Oracefal Analogs
Oracefal Brand Names Mixture
Oracefal Chemical_Formula
C16H17N3O5S
Oracefal RX_link
http://www.rxlist.com/cgi/generic/cefadrox.htm
Oracefal fda sheet
Oracefal msds (material safety sheet)
Oracefal Synthesis Reference
L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)
Oracefal Molecular Weight
363.389 g/mol
Oracefal Melting Point
197oC
Oracefal H2O Solubility
1110 mg/L
Oracefal State
Solid
Oracefal LogP
-0.355
Oracefal Dosage Forms
Capsule; Tablet; Oral liquid
Oracefal Indication
For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes
Oracefal Pharmacology
Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.
Oracefal Absorption
Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.
Oracefal side effects and Toxicity
Nausea, vomiting, diarrhoea, allergic rashes may occur
Oracefal Patient Information
Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial
infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial
infection, patients should be told that although it is common to feel better early in the course of therapy, the
medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1)
decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop
resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.
Oracefal Organisms Affected
Enteric bacteria and other eubacteria
